As well as these potential applications in cancer diagnosis, increased levels of soluble Nectin-4 in serum may contribute to the diagnosis and monitoring of asthma (62) and may also represent a new biomarker for opioid dependence (63, 64). This evidence concerns the gene NECTIN4 and cancer.